Active ingredients

The drug ACOG contains one active pharmaceutical ingredient (API):


Rivaroxaban is a highly selective direct factor Xa inhibitor with oral bioavailability. Inhibition of factor Xa interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade, inhibiting both thrombin formation and development of thrombi. Rivaroxaban does not inhibit thrombin (activated factor II) and no effects on platelets have been demonstrated.

Read about Rivaroxaban

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AF Direct factor Xa inhibitors
Discover more medicines within B01AF01

Authorization and marketing

This brand name is authorized in the following countries: Brazil

This drug has been assigned below unique identifiers within the countries it is being marketed:

Identification scheme
Câmara de Regulação do Mercado de Medicamentos
Identifier(s): 532720070038607, 532720070038707, 532720070038807, 532720070038907, 532720070039007, 532720070039107, 532720070039207, 532720070039307, 532720070039407, 532720070039507, 532720070039607, 532720070039707